JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion

Anders Sundqvist1,2, Masato Morikawa1,3, Jiang Ren4

  • 1Ludwig Cancer Research, Science for Life Laboratory, Box 595, Biomedical Center, Uppsala University, SE-751 24 Uppsala, Sweden.

Nucleic Acids Research
|November 30, 2017
PubMed

Insights

Transforming growth factor-β (TGFβ) promotes breast cancer invasion by altering SMAD2/3 binding and activating AP1 and WNT pathways. This research clarifies how TGFβ drives pro-oncogenic changes in epithelial cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Transforming growth factor-β (TGFβ) paradoxically shifts from tumor suppressor to promoter during tumorigenesis.
  • In breast cancer, SMAD mutations are rare, with SMAD interactions with other transcription factors driving oncogenesis.
  • Understanding TGFβ's pro-oncogenic mechanisms in breast cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate how prolonged TGFβ stimulation alters the genome-wide binding landscape of SMAD2/3 in breast cancer cells.
  • To identify key transcription factors and signaling pathways involved in TGFβ-induced breast cancer cell invasion.
  • To elucidate the regulatory network stabilizing TGFβ-induced pro-oncogenic phenotypes.

Main Methods:

  • Chromatin immunoprecipitation (ChIP)-sequencing to analyze SMAD2/3 binding.
  • De novo motif analysis to identify enriched transcription factor binding sites.
  • Gene expression analysis and pathway enrichment analysis (WNT, AP1).
  • Functional assays involving overexpression and inhibition of WNT pathway components.

Main Results:

  • Prolonged TGFβ stimulation significantly altered the genome-wide SMAD2/3 binding landscape.
  • De novo motif analysis revealed enrichment of activator protein 1 (AP1) motifs alongside SMAD motifs.
  • TGFβ-induced JUNB (an AP1 component) was essential for late invasion-mediating genes, forming a feed-forward loop.
  • Components of the WNT pathway, including WNT7A/B, were enriched in late TGFβ-target genes and promoted TGFβ-induced invasion.

Conclusions:

  • TGFβ signaling reprograms SMAD2/3 binding and induces a regulatory network involving AP1 and WNT pathways in breast cancer.
  • This network stabilizes pro-oncogenic cellular phenotypes, driving cancer cell invasion.
  • The findings provide insights into the mechanisms by which TGFβ promotes breast cancer progression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K